GT Biopharma, Inc. (GTBP) Tops Q3 EPS by 3c

GT Biopharma, Inc. (NASDAQ: GTBP) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on GT Biopharma, Inc. (GTBP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance